Cargando…

MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female

Background Familial Hypocalciuric Hypercalcemia (FHH) is a rare autosomal dominant genetic disorder which causes impaired calcium sensing receptor (CaSR) function which is located in the parathyroid and kidneys. This disorder leads to hypercalcemia, hypocalciuria and normal to moderately elevated pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mudgal, Mayuri, Chaithongdi, Niyutchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550883/
http://dx.doi.org/10.1210/js.2019-MON-540
_version_ 1783424284875554816
author Mudgal, Mayuri
Chaithongdi, Niyutchai
author_facet Mudgal, Mayuri
Chaithongdi, Niyutchai
author_sort Mudgal, Mayuri
collection PubMed
description Background Familial Hypocalciuric Hypercalcemia (FHH) is a rare autosomal dominant genetic disorder which causes impaired calcium sensing receptor (CaSR) function which is located in the parathyroid and kidneys. This disorder leads to hypercalcemia, hypocalciuria and normal to moderately elevated parathyroid hormone (PTH). Here we present a case of asymptomatic FHH diagnosed in the seventh decade of life. Case description A 63-year old Caucasian female was referred to the endocrinology clinic for evaluation of her hypercalcemia. Patient had elevated blood calcium levels (ranging from 10.5-11 mg/dl) since the age of 55. She denied any history of kidney stones, osteoporosis, fracture or malignancy. There was no family history of hypercalcemia. Her other medical history included diabetes mellitus type 2, hypertension, hyperlipidemia and depression. Medications were Metformin, insulin, enalapril, simvastatin, fluoxetine. Laboratory workup revealed calcium 10.1mg/dl, PTH 77.3 pg/ml, 25 OH Vit D 22 ng/ml, Initial urine 24-hour calcium 0mg/24 hr, creatinine 1.2 mg/dl, 24-hour urine creatinine 1.1 mg/dl. DEXA scan with normal bone mineral density. Vitamin D was supplemented and subsequent repeat urine 24-hour calcium had improved but was still low at 29mg/24 hour with urine calcium/creatinine ratio of 0.029. Follow-up blood calcium levels showed fluctuations ranging from 9.4-10.3. Patient was subsequently referred for genetic testing which returned positive for heterozygous mutation in the CASR gene. Discussion FHH is an inherited disorder with prevalence of 1 in 78,000 and presents as benign, lifelong, persistent hypercalcemia and hypocalciuria without hypercalcemic related complications. Patients are mostly asymptomatic but there have been cases of pancreatitis, gall stones and chondrocalcinosis noted in literature from FHH. Conclusion Distinguishing FHH from primary hyperparathyroidism is important as the former is benign and does not require any surgical intervention while latter is cured with parathyroidectomy. This case identifies the role of primary care physicians in timely detection of hypercalcemia and subsequent diagnosis which can prevent unnecessary parathyroid surgical procedures as well as complications from hypercalcemia in patients with primary hyperparathyroidism.
format Online
Article
Text
id pubmed-6550883
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65508832019-06-13 MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female Mudgal, Mayuri Chaithongdi, Niyutchai J Endocr Soc Bone and Mineral Metabolism Background Familial Hypocalciuric Hypercalcemia (FHH) is a rare autosomal dominant genetic disorder which causes impaired calcium sensing receptor (CaSR) function which is located in the parathyroid and kidneys. This disorder leads to hypercalcemia, hypocalciuria and normal to moderately elevated parathyroid hormone (PTH). Here we present a case of asymptomatic FHH diagnosed in the seventh decade of life. Case description A 63-year old Caucasian female was referred to the endocrinology clinic for evaluation of her hypercalcemia. Patient had elevated blood calcium levels (ranging from 10.5-11 mg/dl) since the age of 55. She denied any history of kidney stones, osteoporosis, fracture or malignancy. There was no family history of hypercalcemia. Her other medical history included diabetes mellitus type 2, hypertension, hyperlipidemia and depression. Medications were Metformin, insulin, enalapril, simvastatin, fluoxetine. Laboratory workup revealed calcium 10.1mg/dl, PTH 77.3 pg/ml, 25 OH Vit D 22 ng/ml, Initial urine 24-hour calcium 0mg/24 hr, creatinine 1.2 mg/dl, 24-hour urine creatinine 1.1 mg/dl. DEXA scan with normal bone mineral density. Vitamin D was supplemented and subsequent repeat urine 24-hour calcium had improved but was still low at 29mg/24 hour with urine calcium/creatinine ratio of 0.029. Follow-up blood calcium levels showed fluctuations ranging from 9.4-10.3. Patient was subsequently referred for genetic testing which returned positive for heterozygous mutation in the CASR gene. Discussion FHH is an inherited disorder with prevalence of 1 in 78,000 and presents as benign, lifelong, persistent hypercalcemia and hypocalciuria without hypercalcemic related complications. Patients are mostly asymptomatic but there have been cases of pancreatitis, gall stones and chondrocalcinosis noted in literature from FHH. Conclusion Distinguishing FHH from primary hyperparathyroidism is important as the former is benign and does not require any surgical intervention while latter is cured with parathyroidectomy. This case identifies the role of primary care physicians in timely detection of hypercalcemia and subsequent diagnosis which can prevent unnecessary parathyroid surgical procedures as well as complications from hypercalcemia in patients with primary hyperparathyroidism. Endocrine Society 2019-04-30 /pmc/articles/PMC6550883/ http://dx.doi.org/10.1210/js.2019-MON-540 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Bone and Mineral Metabolism
Mudgal, Mayuri
Chaithongdi, Niyutchai
MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female
title MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female
title_full MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female
title_fullStr MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female
title_full_unstemmed MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female
title_short MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female
title_sort mon-540 familial hypocalciuric hypercalcemia diagnosed in a 63-year-old female
topic Bone and Mineral Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550883/
http://dx.doi.org/10.1210/js.2019-MON-540
work_keys_str_mv AT mudgalmayuri mon540familialhypocalciurichypercalcemiadiagnosedina63yearoldfemale
AT chaithongdiniyutchai mon540familialhypocalciurichypercalcemiadiagnosedina63yearoldfemale